Literature DB >> 30375575

Lansoprazole-Induced Subacute Cutaneous Lupus Erythematosus.

İsa An1, Vasfiye Demir2, İbrahim Ibiloğlu3, Sedat Akdeniz1, Derya Uçmak1.   

Abstract

Entities:  

Year:  2017        PMID： 30375575      PMCID： PMC6190992          DOI： 10.5606/ArchRheumatol.2017.6237

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN： 2148-5046            Impact factor:   1.472


× No keyword cloud information.
  5 in total

Review 1.  A systematic review of drug-induced subacute cutaneous lupus erythematosus.

Authors:  G C Lowe; G Lowe; C L Henderson; R H Grau; C B Hansen; R D Sontheimer
Journal:  Br J Dermatol       Date:  2011-02-17       Impact factor: 9.302

Review 2.  Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.

Authors:  Richard D Sontheimer
Journal:  Autoimmun Rev       Date:  2004-11-12       Impact factor: 9.754

Review 3.  Drug-induced lupus erythematosus.

Authors:  M Pretel; L Marquès; A España
Journal:  Actas Dermosifiliogr       Date:  2012-11-17

Review 4.  Hypersensitivity reactions to proton pump inhibitors.

Authors:  Yoon-Seok Chang
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-08

5.  Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.

Authors:  L H Sandholdt; R Laurinaviciene; A Bygum
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302
  5 in total
  1 in total

1.  Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.

Authors:  Sukhjot Kaur; Palvi Singla; Sandeep Kaur; Amit Kansal; Aditi Bansal; Aminder Singh
Journal:  Indian Dermatol Online J       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.